Challenging the norm: Epicutaneous immunotherapy for canine atopic dermatitis
- PMID: 37984458
- DOI: 10.1111/all.15946
Challenging the norm: Epicutaneous immunotherapy for canine atopic dermatitis
References
REFERENCES
-
- Marsella R, Benedetto A. Atopic dermatitis in animals and people: an update and comparative review. Vet Sci. 2017;4(37):1-19.
-
- Mueller RS, Jensen-Jarolim E, Roth-Walter F, et al. Allergen immunotherapy in people, dogs, cats and horses - differences, similarities and research needs. Allergy. 2018;73(10):1989-1999.
-
- Ramió-Lluch L, Brazís P, Ferrer L, et al. Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner compliance the main success-limiting factor? Vet Rec. 2020;187(12):493.
-
- Yepes-Nuñez J, Guyatt G, Gómez-Escobar L, et al. Allergen immunotherapy for atopic dermatitis: systematic review and meta-analysis of benefits and harms. J Allergy Clin Immunol. 2023;151(1):147-158.
-
- Senti G, Moos S, Tay F, et al. Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy. 2015;70(6):707-710.
Publication types
MeSH terms
Grants and funding
- LA/P/0059/2020/Associate Laboratory for Animal and Veterinary Sciences
- UIDB/00276/2020/Centre for Interdisciplinary Research in Animal Health
- UI/BD/153072/2022/Foundation for Science and Technology
- UIDB/04138/2020/Foundation for Science and Technology
- UIDP/04138/2020/Foundation for Science and Technology